| 1.6 |
6.3 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.3 |
10.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.8 |
8.9 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.7 |
2.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.7 |
2.2 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.7 |
6.2 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.6 |
1.8 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.4 |
3.0 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.3 |
3.4 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
1.0 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.3 |
3.6 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.3 |
1.3 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.3 |
2.2 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.3 |
4.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
1.0 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.3 |
0.8 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
1.0 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 |
1.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 |
0.7 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 |
0.7 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 |
2.1 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.2 |
1.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
4.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
1.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
0.6 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.2 |
1.7 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.2 |
0.6 |
GO:1900164 |
nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) embryonic heart tube left/right pattern formation(GO:0060971) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.2 |
1.2 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.2 |
1.8 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
7.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
0.7 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
1.9 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.5 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 |
0.8 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.2 |
3.4 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
0.5 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
0.6 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
1.4 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.3 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.1 |
0.7 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
1.2 |
GO:2000809 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.1 |
0.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.8 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.4 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.1 |
0.4 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
1.4 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.6 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.2 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
0.4 |
GO:0060423 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) negative regulation of mitotic cell cycle, embryonic(GO:0045976) foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) positive regulation of branching involved in lung morphogenesis(GO:0061047) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.1 |
1.0 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.7 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.3 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.5 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 |
0.8 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.1 |
1.0 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
1.5 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.9 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
1.1 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.6 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.6 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.8 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
0.5 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.1 |
1.5 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.1 |
0.3 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.1 |
1.0 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
0.4 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.2 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 |
0.2 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.8 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
2.0 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.1 |
0.3 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 |
0.5 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.3 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.5 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.3 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.1 |
0.3 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.1 |
1.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
1.3 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.2 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.0 |
1.0 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.3 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.0 |
0.1 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.0 |
0.8 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.3 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.1 |
GO:0032696 |
forebrain radial glial cell differentiation(GO:0021861) negative regulation of interleukin-13 production(GO:0032696) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.0 |
0.1 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.0 |
0.2 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.0 |
1.4 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.3 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.5 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.0 |
1.4 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.0 |
0.9 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.6 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.0 |
0.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.1 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 |
0.6 |
GO:0010880 |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.0 |
0.2 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.8 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
1.6 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.0 |
0.2 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
3.8 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.2 |
GO:0035280 |
miRNA mediated inhibition of translation(GO:0035278) miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
1.5 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.3 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.8 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.7 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
1.2 |
GO:0051017 |
actin filament bundle assembly(GO:0051017) |
| 0.0 |
0.2 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.2 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.0 |
0.1 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.3 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
1.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.3 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
2.3 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.0 |
0.2 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.3 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.1 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.0 |
0.1 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.4 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
2.7 |
GO:0006470 |
protein dephosphorylation(GO:0006470) |
| 0.0 |
0.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.5 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.9 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
0.1 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
